Annual Report 2024

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2024 119 The United Laboratories International Holdings Limited Annual Report 2024 31. SHARE CAPITAL Number of shares Amount HK$’000 Ordinary shares of HK$0.01 each: Authorised: At 1 January 2023, 31 December 2023 and 2024 3,800,000,000 38,000 Issued and fully paid: At 1 January 2023, 31 December 2023 and 2024 1,817,026,508 18,170 RMB’000 Shown in the consolidated financial statements as: At 31 December 2023 and 2024 16,965 Notes: (i) During the year ended 31 December 2024, the Company repurchased its own ordinary shares through the Stock Exchange as follows: Month of repurchase No. of ordinary shares of HK$0.01 each Price per share Aggregate consideration paid Highest Lowest HK$ HK$ HK$’000 October 3,700,000 11.20 10.04 40,382 RMB’000 Shown in the consolidated financial statements as: At 31 December 2024 36,577 (ii) At 31 December 2024, the Company had outstanding treasury shares of 93,820 (31 December 2023: Nil) shares. None of the Company’s subsidiaries purchased, sold or redeemed any of the Company’s listed securities during both years.